Coles N Anthony's Form 4 filing
Regeneron Pharmaceuticals, Inc. (REGN) · filed Dec 30, 2022
- Accession no.
- 0001883850-22-000143
- Filed
- Dec 30, 2022
- Trade date
- Dec 28, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 10 non-derivative transactions and 2 derivative transactions. Open-market sales total $4.11M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Coles N AnthonyCIK 0001197018 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 28, 2022 | Common Stock | MOption exerciseAcquired | +2,145 | $374.12 | +$802,487.4 | 3,238 | Direct | |
| Dec 28, 2022 | Common Stock | MOption exerciseAcquired | +3,613 | $482.68 | +$1,743,922.84 | 6,851 | Direct | |
| Dec 28, 2022 | Common Stock | SSaleDisposed | −181 | $707.87 | −$128,124.47 | 6,670 | Direct | |
| Dec 28, 2022 | Common Stock | SSaleDisposed | −1 | $709.92 | −$709.92 | 6,669 | Direct | |
| Dec 28, 2022 | Common Stock | SSaleDisposed | −679 | $710.63F2 | −$482,517.77 | 5,990 | Direct | |
| Dec 28, 2022 | Common Stock | SSaleDisposed | −100 | $711.95 | −$71,195 | 5,890 | Direct | |
| Dec 28, 2022 | Common Stock | SSaleDisposed | −1,198 | $713.66F3 | −$854,964.68 | 4,692 | Direct | |
| Dec 28, 2022 | Common Stock | SSaleDisposed | −1,022 | $714.61F4 | −$730,331.42 | 3,670 | Direct | |
| Dec 28, 2022 | Common Stock | SSaleDisposed | −2,266 | $715.48F5 | −$1,621,277.68 | 1,404 | Direct | |
| Dec 28, 2022 | Common Stock | SSaleDisposed | −311 | $716.08F6 | −$222,700.88 | 1,093 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 28, 2022 | Common Stock | MOption exerciseDisposed | −2,145 | $0.00 | $0 | 0 | Direct | |
| Dec 28, 2022 | Common Stock | MOption exerciseDisposed | −3,613 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents volume-weighted average price of sales of 679 shares of Company stock on December 28, 2022 at prices ranging from $710.48 to $710.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 28, 2022 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Represents volume-weighted average price of sales of 1,198 shares of Company stock on December 28, 2022 at prices ranging from $713.17 to $713.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 28, 2022 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Represents volume-weighted average price of sales of 1,022 shares of Company stock on December 28, 2022 at prices ranging from $714.00 to $714.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 28, 2022 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
Represents volume-weighted average price of sales of 2,266 shares of Company stock on December 28, 2022 at prices ranging from $715.04 to $715.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 28, 2022 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F6
Represents volume-weighted average price of sales of 311 shares of Company stock on December 28, 2022 at prices ranging from $716.02 to $716.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 28, 2022 at each separate price.
Referenced by the price of 1 transaction in Table I.